- Investing Ideas
- Global Pharmaceuticals & Biotech Breakout Stocks
Global Pharmaceuticals & Biotech Breakout Stocks
Results
14
Stocks where the price continues to rise after more than a year of consistent gains.
14 companies
Hansa Biopharma
Market Cap: SEK 4.0b
A biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe.
HNSA
SEK 39.42
7D
21.9%
1Y
42.0%
EI- Nile for Pharmaceuticals and Chemical Industries
Market Cap: ج.م11.8b
Develops, produces, and sells pharmaceutical products in Egypt.
NIPH
ج.م236.01
7D
21.4%
1Y
276.3%
Prescient Therapeutics
Market Cap: AU$96.7m
A clinical stage oncology company, develops drugs for the treatment of haematological and solid cancers in Australia.
PTX
AU$0.092
7D
26.0%
1Y
104.4%
EOM Pharmaceuticals Holdings
Market Cap: US$31.4m
A clinical-stage biotechnology company, focuses on the development of drugs to transform therapeutic paradigms and enhance quality of life in patients suffering from debilitating and deadly diseases in the United States.
IMUC
US$0.21
7D
39.2%
1Y
108.8%
PharmaCielo
Market Cap: CA$15.6m
Together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada.
PCLO
CA$0.075
7D
25.0%
1Y
50.0%
Invex Therapeutics
Market Cap: AU$9.0m
A biopharmaceutical company, engages in the research and development of treatments for neurological conditions in Australia.
IXC
AU$0.12
7D
20.0%
1Y
44.6%
Delex Healthcare Group
Market Cap: US$6.0m
Engages in the development and distribution of pharmaceutical and healthcare products in Asia and the Philippines.
DELX
US$0.0085
7D
46.6%
1Y
9.8%
BPH Global
Market Cap: AU$4.7m
Engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Southeast Asia.
BP8
AU$0.002
7D
33.3%
1Y
0%
International Stem Cell
Market Cap: US$2.2m
A clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally.
ISCO
US$0.31
7D
74.4%
1Y
107.8%
CBD Life Sciences
Market Cap: US$1.8m
Engages in the development and marketing a line of cannabidiol based organic products.
CBDL
US$0.0003
7D
200.0%
1Y
0%
Myrexis
Market Cap: US$241.4k
Focuses on identifying, evaluating, and making financial investments in life sciences assets.
MYRX
US$0.007
7D
775.0%
1Y
3,400.0%
Cannonau
Market Cap: US$72.5k
Engages in the provision of cannabidiol based products.
CNNC
US$0.0003
7D
50.0%
1Y
200.0%
Pressure BioSciences
Market Cap: US$30.1k
Develops and sells high pressure technology-based instruments, consumables, and services for life sciences and other industries worldwide.
PBIO
US$0.0007
7D
250.0%
1Y
133.3%
eFFECTOR Therapeutics
Market Cap: US$940.0
A biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer.
EFTR
US$0.0008
7D
33.3%
1Y
300.0%